YU49047B - Novi derivati 2-cijano 3-hidroksi propenamida, postupak za njihovo dobivanje, njihova primena kao lekova i farmaceutski preparati koji ih sadrže - Google Patents

Novi derivati 2-cijano 3-hidroksi propenamida, postupak za njihovo dobivanje, njihova primena kao lekova i farmaceutski preparati koji ih sadrže

Info

Publication number
YU49047B
YU49047B YU82593A YU82593A YU49047B YU 49047 B YU49047 B YU 49047B YU 82593 A YU82593 A YU 82593A YU 82593 A YU82593 A YU 82593A YU 49047 B YU49047 B YU 49047B
Authority
YU
Yugoslavia
Prior art keywords
propenamides
medicaments
cyano
hydroxy
novel
Prior art date
Application number
YU82593A
Other languages
English (en)
Other versions
YU82593A (sh
Inventor
Elizabeth Anne Kuo
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU82593A publication Critical patent/YU82593A/sh
Publication of YU49047B publication Critical patent/YU49047B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

2-cijano-3-hidroksi-propenamida opšte formule (I) naznačena time, što - A, B i E svaki predstavlja =CH-grupu ili atom azota, gde bar jedan od A, B I E predstavlja atom azota, - R predstavlja cikloalkil radikal koji sadrži 3 do 6 atoma ugljenika, alkenil radikal sa 2 do 6 atoma ugljenika, alkinil radikal sa 2 do 6 atoma ugljenika, - R1 predstavlja atom vodonika, alkil radikal sa 1 do 3 atoma ugljenika, - R2 i R3 identični ili različiti, predstavljaju atom vodonika, atom halogena, cijano grupu, nitro grupu, linearni ili račvasti radikal sa 1 do 6 atoma ugljenika, cikloalkil radikal sa 3 do 6 atoma ugljenika, linerani ili račvasti radikal sa 1 do 6 atoma ugljenika, alkiltio radikal sa 1 do 6 atoma ugljenika, -(CH2)m-CX3 radikal, -O-(CH2)m-CX3 radikal, -S-(CH2)m-CX3, -O-(CX2)m-CX3, -S-(CX2)m-CX3 radikal, gde m predstavlja broj između 0 i 3, a X predstavlja atom halogena, -CO-R4 grupa u kojoj R4 predstavlja atom vodonika, linerani ili račvasti alkil radikal koji sadrži 1 do 6 atoma ugljenika, cikloalkil radikal sa 3 do 6 atoma ugljenika, ili R2 i R3 grade zajedno -O-CH2-O-grupu njihovi tautomerni oblici kao i njihove adicione soli sa mineralnim ili organskim bazama. Prijava sadrži još 2 nezavisna i 9 zavisnih zahteva.
YU82593A 1993-01-05 1993-12-29 Novi derivati 2-cijano 3-hidroksi propenamida, postupak za njihovo dobivanje, njihova primena kao lekova i farmaceutski preparati koji ih sadrže YU49047B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939300083A GB9300083D0 (en) 1993-01-05 1993-01-05 Chemical compounds

Publications (2)

Publication Number Publication Date
YU82593A YU82593A (sh) 1996-07-24
YU49047B true YU49047B (sh) 2003-07-07

Family

ID=10728304

Family Applications (1)

Application Number Title Priority Date Filing Date
YU82593A YU49047B (sh) 1993-01-05 1993-12-29 Novi derivati 2-cijano 3-hidroksi propenamida, postupak za njihovo dobivanje, njihova primena kao lekova i farmaceutski preparati koji ih sadrže

Country Status (33)

Country Link
US (1) US5346912A (sh)
EP (1) EP0606175B1 (sh)
JP (1) JP3334988B2 (sh)
KR (1) KR100295717B1 (sh)
CN (1) CN1042935C (sh)
AT (1) ATE128968T1 (sh)
AU (1) AU663017B2 (sh)
BR (1) BR9400017A (sh)
CA (1) CA2112866C (sh)
CZ (1) CZ283948B6 (sh)
DE (1) DE69400024T2 (sh)
DK (1) DK0606175T3 (sh)
EE (1) EE03001B1 (sh)
ES (1) ES2078130T3 (sh)
FI (1) FI106553B (sh)
GB (1) GB9300083D0 (sh)
GR (1) GR3017723T3 (sh)
HR (1) HRP940006B1 (sh)
HU (1) HU216835B (sh)
IL (1) IL107788A (sh)
LT (1) LT3766B (sh)
LV (1) LV10712B (sh)
MX (1) MX9400274A (sh)
NO (1) NO300839B1 (sh)
NZ (1) NZ250520A (sh)
PL (1) PL175135B1 (sh)
RU (1) RU2126387C1 (sh)
SI (1) SI9300686A (sh)
SK (1) SK280508B6 (sh)
TW (1) TW259785B (sh)
UA (1) UA40573C2 (sh)
YU (1) YU49047B (sh)
ZA (1) ZA939118B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006153A1 (en) * 1998-07-28 2000-02-10 Smithkline Beecham Corporation Propenamides as ccr5 modulators
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US8642597B2 (en) 2007-08-27 2014-02-04 Basf Se Pyrazole compounds for controlling invertebrate pests
BRPI0919061B1 (pt) 2008-09-24 2017-07-18 Basf Se Pyrazole compounds, method for controlling invertebrate pests, method of protecting plant and / or plant propagation material, agricultural composition and use of a compound
JP2012532175A (ja) 2009-07-06 2012-12-13 ビーエーエスエフ ソシエタス・ヨーロピア 無脊椎動物系害虫防除用ピリダジン化合物
ES2472918T3 (es) 2009-07-06 2014-07-03 Basf Se Compuestos de piridazina para controlar plagas de invertebrados
EP2456308A2 (en) 2009-07-24 2012-05-30 Basf Se Pyridine derivatives for controlling invertrebate pests
EA201691057A1 (ru) 2013-11-22 2016-10-31 Джензим Корпорейшн Новые способы лечения нейродегенеративных заболеваний
CN105693574B (zh) * 2014-11-25 2017-12-19 中国科学院大连化学物理研究所 2‑烷硫基烯酰胺衍生物及其合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4435407A (en) * 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
DE3534440A1 (de) 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4888357A (en) 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
DE59010701D1 (de) * 1990-05-18 1997-05-22 Hoechst Ag Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide

Also Published As

Publication number Publication date
FI940031A (fi) 1994-07-06
EP0606175A1 (fr) 1994-07-13
KR940018363A (ko) 1994-08-16
FI106553B (fi) 2001-02-28
NZ250520A (en) 1996-08-27
CZ283948B6 (cs) 1998-07-15
IL107788A0 (en) 1994-02-27
KR100295717B1 (ko) 2001-11-05
HRP940006B1 (en) 1999-12-31
LTIP1634A (en) 1995-02-27
CN1042935C (zh) 1999-04-14
LV10712A (lv) 1995-06-20
NO300839B1 (no) 1997-08-04
NO940020D0 (no) 1994-01-04
ZA939118B (en) 1995-01-18
UA40573C2 (uk) 2001-08-15
CN1097005A (zh) 1995-01-04
US5346912A (en) 1994-09-13
ATE128968T1 (de) 1995-10-15
CA2112866A1 (fr) 1994-07-06
HRP940006A2 (en) 1996-10-31
HU216835B (hu) 1999-09-28
FI940031A0 (fi) 1994-01-04
CZ292193A3 (en) 1994-07-13
JP3334988B2 (ja) 2002-10-15
JPH06211793A (ja) 1994-08-02
AU663017B2 (en) 1995-09-21
HUT71471A (en) 1995-11-28
SK149593A3 (en) 1994-12-07
ES2078130T3 (es) 1995-12-01
TW259785B (en) 1995-10-11
DE69400024T2 (de) 1996-04-04
RU94000064A (ru) 1996-07-10
HU9400033D0 (en) 1994-05-30
RU2126387C1 (ru) 1999-02-20
IL107788A (en) 1998-08-16
EE03001B1 (et) 1997-06-16
CA2112866C (fr) 2007-03-13
BR9400017A (pt) 1994-08-02
DE69400024D1 (de) 1995-11-16
GB9300083D0 (en) 1993-03-03
NO940020L (sh) 1994-07-06
LT3766B (en) 1996-03-25
GR3017723T3 (en) 1996-01-31
SI9300686A (en) 1994-09-30
PL175135B1 (pl) 1998-11-30
AU5213093A (en) 1994-07-14
PL301774A1 (en) 1994-07-11
MX9400274A (es) 1994-08-31
LV10712B (en) 1995-12-20
DK0606175T3 (da) 1996-02-19
SK280508B6 (sk) 2000-03-13
EP0606175B1 (fr) 1995-10-11
YU82593A (sh) 1996-07-24

Similar Documents

Publication Publication Date Title
CS183091A3 (en) Cephalosporins, having in the position 3 a propenyl radical substituted byquaternary ammonium, process of their preparation, their use as medicaments andpharmaceutical compositions in which said cephalosporins are comprised
YU49047B (sh) Novi derivati 2-cijano 3-hidroksi propenamida, postupak za njihovo dobivanje, njihova primena kao lekova i farmaceutski preparati koji ih sadrže
IL109610A0 (en) Amide derivatives, their preparation and pharmaceutical compositions containing them
SI0870761T1 (en) Thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
DE3880304T2 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
GR3033175T3 (en) Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
DE69229017T2 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider